We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Thallium Intoxication Treated With Dithizone and Hemodialysis

George Paulson, MD; George Vergara, MD; John Young, MS; Morris Bird, MD
Arch Intern Med. 1972;129(1):100-103. doi:10.1001/archinte.1972.00320010104013.
Text Size: A A A
Published online


Thallous sulfate is an extremely toxic substance. Ingestion of 0.2 to 1 gm of this tasteless, odorless powder can be lethal.1 Rodenticides and depilatory agents that contain thallium are now restricted in the United States, but thallitoxicosis can still present as a diagnostic problem.2,3 This paper reports thallitoxicosis in four members of one family and describes the results in one patient of treatment with dithizone (diphenylthiocarbazone), potassium chloride, and activated charcoal. The effects of hemodialysis are reported, and the methods used to measure thallium levels are summarized.

Patient Summaries 

Patient 1.  —This 56-year-old white woman was the wife of patient 3. A substernal sensation of tightness along with shortness of breath developed several weeks after the death of her mother-in-law, patient 2. Two days later she noted swelling and numbness of her feet and was considered to have an hysterical hyperventilation syndrome. The following day muscle weakness and


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.